BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34126087)

  • 1. Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals.
    Hariton E; Shirazi TN; Douglas NC; Hershlag A; Briggs SF
    Am J Obstet Gynecol; 2021 Nov; 225(5):515.e1-515.e10. PubMed ID: 34126087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian reserve markers in women using various hormonal contraceptives.
    Landersoe SK; Forman JL; Birch Petersen K; Larsen EC; Nøhr B; Hvidman HW; Nielsen HS; Nyboe Andersen A
    Eur J Contracept Reprod Health Care; 2020 Feb; 25(1):65-71. PubMed ID: 31852271
    [No Abstract]   [Full Text] [Related]  

  • 3. Contraceptive-specific antimüllerian hormone values in reproductive-age women: a population study of 42,684 women.
    Nelson SM; Ewing BJ; Gromski PS; Briggs SF
    Fertil Steril; 2023 Jun; 119(6):1069-1077. PubMed ID: 36801456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels.
    Bernardi LA; Weiss MS; Waldo A; Harmon Q; Carnethon MR; Baird DD; Wise LA; Marsh EE
    Fertil Steril; 2021 Jul; 116(1):208-217. PubMed ID: 33752880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
    Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
    Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women.
    Hawkins Bressler L; Bernardi LA; De Chavez PJ; Baird DD; Carnethon MR; Marsh EE
    Am J Obstet Gynecol; 2016 Dec; 215(6):758.e1-758.e9. PubMed ID: 27418446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
    Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
    BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-müllerian hormone level is not altered in women using hormonal contraceptives.
    Li HW; Wong CY; Yeung WS; Ho PC; Ng EH
    Contraception; 2011 Jun; 83(6):582-5. PubMed ID: 21570558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.
    Somunkiran A; Yavuz T; Yucel O; Ozdemir I
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):196-201. PubMed ID: 17335955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
    Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ
    Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
    Lopez LM; Chen M; Mullins Long S; Curtis KM; Helmerhorst FM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009849. PubMed ID: 26195091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
    Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
    Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
    Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion.
    Kucera R; Ulcova-Gallova Z; Topolcan O
    Gynecol Endocrinol; 2016; 32(5):383-5. PubMed ID: 26651155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of anti-Müllerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome.
    Safier LZ; Grossman LC; Chan CW; Sauer MV; Lobo RA; Douglas NC
    Int J Gynaecol Obstet; 2016 Oct; 135(1):73-6. PubMed ID: 27350232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.
    Jung S; Allen N; Arslan AA; Baglietto L; Brinton LA; Egleston BL; Falk R; Fortner RT; Helzlsouer KJ; Idahl A; Kaaks R; Lundin E; Merritt M; Onland-Moret C; Rinaldi S; Sánchez MJ; Sieri S; Schock H; Shu XO; Sluss PM; Staats PN; Travis RC; Tjønneland A; Trichopoulou A; Tworoger S; Visvanathan K; Krogh V; Weiderpass E; Zeleniuch-Jacquotte A; Zheng W; Dorgan JF
    Fertil Steril; 2017 Apr; 107(4):1012-1022.e2. PubMed ID: 28366409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients.
    Mes-Krowinkel MG; Louwers YV; Mulders AG; de Jong FH; Fauser BC; Laven JS
    Fertil Steril; 2014 Jun; 101(6):1757-65.e1. PubMed ID: 24680368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.